# OnCo record paper-bear-pancreatic-immunotherapy-review-cancer-cell-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bear-pancreatic-immunotherapy-review-cancer-cell-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bear-pancreatic-immunotherapy-review-cancer-cell-2020" ;
  schema:name "Challenges and opportunities for pancreatic cancer immunotherapy"@en ;
  schema:description "A review of why immune drugs fail in pancreatic cancer: the tumour's own driver genes build immune suppression from the start, single agents do nothing, and the proposed answer is to combine antigen delivery, T-cell support and stromal reprogramming."@en ;
  schema:url <https://onco.cc/key-papers/paper-bear-pancreatic-immunotherapy-review-cancer-cell-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.ccell.2020.08.004>, <https://pubmed.ncbi.nlm.nih.gov/32946773/> ;
  schema:sameAs <https://doi.org/10.1016/j.ccell.2020.08.004> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Bear AS, Vonderheide RH, O'Hara MH." ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:institutions <https://onco.cc/institutions/penn-abramson/> ;
  onco:pathways <https://onco.cc/pathways/pd1-checkpoint/>, <https://onco.cc/pathways/cancer-immunity-cycle/>, <https://onco.cc/pathways/immune-desert-exclusion/> ;
  onco:terms <https://onco.cc/terms/cold-vs-hot/>, <https://onco.cc/terms/immune-exclusion/> ;
  onco:people <https://onco.cc/people/robert-vonderheide/> ;
  onco:journals <https://onco.cc/journals/cancer-cell/> .